Skip to main content
Log in

Strategies for managing antidepressant-induced sexual dysfunction: A review

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Sexual dysfunction is a common side effect of most antidepressants. Lower rates are reported with some newer agents such as reboxetine and bupropion. The evidence base for its management is limited but growing, with most approaches only tested in a small number of trials. Available strategies include watchful waiting, the use of short drug holidays, and a change of antidepressant. Many specific antidotes have been trialed but with lack of convincing benefit in most cases. However, where antidepressants cause erectile dysfunction, the use of sildenafisl has the largest and most consistent evidence base.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rudkin L, Taylor MJ, Hawton K: Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev 2004, 4:CD003382. Periodically updated systematic review of RCTs of strategies for managing antidepressant-induced sexual dysfunction.

    PubMed  Google Scholar 

  2. Angst J: Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 1998, 13(Suppl 6):S1-S4.

    Article  PubMed  Google Scholar 

  3. Montgomery SA, Baldwin DS, Riley A: Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002, 69:119–140.

    Article  PubMed  CAS  Google Scholar 

  4. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F: Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001, 62(Suppl 3):10–21.

    PubMed  CAS  Google Scholar 

  5. Clayton AH, Pradko JF, Croft HA, et al.: Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002, 63:357–366.

    PubMed  Google Scholar 

  6. Williams VS, Baldwin DS, Hogue SL, et al.: Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a crosssectional patient survey. J Clin Psychiatry 2006, 67:204 -210.

    PubMed  CAS  Google Scholar 

  7. Croft H, Settle E, Jr, Houser T, et al.: A placebo-controlled comparison of the antidepressant Efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999, 21:643–658.

    Article  PubMed  CAS  Google Scholar 

  8. Coleman CC, Cunningham LA, Foster VJ, et al.: Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry 1999, 11:205–215.

    Article  PubMed  CAS  Google Scholar 

  9. Coleman CC, King BR, Bolden-Watson C, et al.: A placebocontrolled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 2001, 23:1040–1058.

    Article  PubMed  CAS  Google Scholar 

  10. Clayton AH, Croft HA, Horrigan JP, et al.: Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006, 67:736–746.

    Article  PubMed  CAS  Google Scholar 

  11. Kennedy SH, Fulton KA, Bagby RM, et al.: Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 2006, 51:234–242.

    PubMed  Google Scholar 

  12. Clayton AH, Zajecka J, Ferguson JM, et al.: Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003, 18:151–156.

    Article  PubMed  Google Scholar 

  13. Baldwin D, Bridgman K, Buis C: Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine. J Psychopharmacol 2006, 20:91–96.

    Article  PubMed  CAS  Google Scholar 

  14. Langworth S, Bodlund O, Agren H: Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder. J Clin Psychopharmacol 2006, 26:121–127.

    Article  PubMed  CAS  Google Scholar 

  15. Delgado PL, Brannan SK, Mallinckrodt CH, et al.: Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005, 66:686–692.

    PubMed  Google Scholar 

  16. Ferguson JM, Shrivastava RK, Stahl SM, et al.: Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry 2001, 62:24–29.

    Article  PubMed  CAS  Google Scholar 

  17. Nurnberg HG, Gelenberg A, Hargreave TB, et al.: Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001, 158:1926–1928.

    Article  PubMed  CAS  Google Scholar 

  18. Ginsberg DL, Adler L, McCullough A, et al.: Sildenafil treatment of serotonin-reuptake inhibitor (SRI)-induced sexual dysfunction. Paper presented at 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting. Phoenix, AZ; May 28–31, 2001.

  19. Nurnberg HG, Hensley PL, Gelenberg AJ, et al.: Treatment of antidepressant-associated sexual dysfunction with sildenafil. JAMA 2003, 289:56–64.

    Article  PubMed  CAS  Google Scholar 

  20. Fava M, Nurnberg HG, Seidman SN, et al.: Efficacy and safety of sildenafil in men with serotonergic antidepressantassociated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2006, 67:240–246. Largest single randomized trial indicating benefit of sildenafil in antidepressant-induced erectile dysfunction.

    PubMed  CAS  Google Scholar 

  21. Segraves RT, Stevenson RW, Lee J, et al.: Tadalafil treatment of erectile dysfunction in men on antidepressants. Paper presented at 157th Annual Meeting of the American Psychiatric Association. New York; May 1–6, 2004.

  22. Clayton AH, Warnock JK, Kornstein SG, et al.: A placebocontrolled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004, 65:62–67.

    PubMed  CAS  Google Scholar 

  23. Masand PS, Ashton AK, Gupta S, Frank B: Sustainedrelease bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001, 158:805–807.

    Article  PubMed  CAS  Google Scholar 

  24. Debattista C, Solvason B, Poirier J, et al.: A placebocontrolled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRIinduced sexual dysfunction. J Clin Psychiatry 2005, 66:844–848.

    Article  PubMed  CAS  Google Scholar 

  25. Landen M, Eriksson E, Agren H, Fahlen T: Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999, 19:268–271.

    Article  PubMed  CAS  Google Scholar 

  26. Michelson D, Bancroft J, Targum S, et al.: Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry 2000, 157:239–243.

    Article  PubMed  CAS  Google Scholar 

  27. Kang BJ, Lee SJ, Kim MD, Cho MJ: A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressantinduced sexual dysfunction. Hum Psychopharmacol 2002, 17:279–284.

    Article  PubMed  Google Scholar 

  28. Wheatley D: Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol 2004, 19:545–548.

    Article  PubMed  Google Scholar 

  29. Jespersen S, Berk M, Van Wyk C, et al.: A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. Int Clin Psychopharmacol 2004, 19:161–164.

    Article  PubMed  Google Scholar 

  30. Nelson EB, Shah VN, Welge JA, Keck PE: A placebo-controlled, crossover trial of granisetron in SRI-induced sexual dysfunction. J Clin Psychiatry 2001, 62:469–473.

    Article  PubMed  CAS  Google Scholar 

  31. Michelson D, Kociban K, Tamura R, Morrison MF: Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 2002, 36:147–152.

    Article  PubMed  Google Scholar 

  32. Ernst E, Pittler MH: Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998, 159:433–436.

    Article  PubMed  CAS  Google Scholar 

  33. Meston CM: A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction. J Sex Marital Ther 2004, 30:57–68.

    Article  PubMed  Google Scholar 

  34. Rothschild AJ: Selective serotonin reuptake inhibitorinduced sexual dysfunction: Efficacy of a drug holiday. Am J Psychiatry 1995, 152:1514–1516.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew J. Taylor MA, MRC Psych.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, M.J. Strategies for managing antidepressant-induced sexual dysfunction: A review. Curr Psychiatry Rep 8, 431–436 (2006). https://doi.org/10.1007/s11920-006-0047-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-006-0047-6

Keywords

Navigation